Atea Pharmaceuticals EV | AVIR

EV Jährlich Atea Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
370 M	216 M	257 M	128 M	38.9 M	368 M	50 M	36.4 M	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
370 M	36.4 M	183 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
AnaptysBio ANAB	1.46 B	$ 51.0	1.83 %	$ 1.48 B	USA
Allakos ALLK	31 K	-	-	$ 28.6 M	USA
Black Diamond Therapeutics BDTX	134 M	$ 1.88	0.53 %	$ 107 M	USA
Clovis Oncology CLVS	870 M	-	-7.23 %	$ 13 M	USA
Concert Pharmaceuticals CNCE	15.7 M	-	-	$ 401 M	USA
Evelo Biosciences EVLO	48.5 M	-	-14.46 %	$ 27.9 M	USA
BioMarin Pharmaceutical BMRN	11.9 B	$ 60.26	0.06 %	$ 11.6 B	USA
BioNTech SE BNTX	17.1 B	$ 98.52	0.24 %	$ 23.8 B	Germany
Can-Fite BioPharma Ltd. CANF	-721 K	$ 2.17	0.46 %	$ 3.57 M	Israel
Freeline Therapeutics Holdings plc FRLN	248 M	-	-	$ 384 M	Britain
Genocea Biosciences GNCA	64.4 M	-	-15.0 %	$ 3.04 M	USA
Catalyst Biosciences CBIO	986 M	$ 13.99	0.84 %	$ 1.25 B	USA
C4 Therapeutics CCCC	262 M	$ 2.98	0.3 %	$ 247 M	USA
Codexis CDXS	157 M	$ 1.32	1.09 %	$ 115 M	USA
Amryt Pharma plc AMYT	2.89 B	-	-	$ 621 M	Britain
Cerus Corporation CERS	632 M	$ 2.62	0.38 %	$ 499 M	USA
G1 Therapeutics GTHX	227 M	-	-	$ 370 M	USA
Coherus BioSciences CHRS	335 M	$ 1.13	0.43 %	$ 132 M	USA
Celldex Therapeutics CLDX	2.07 B	$ 31.1	1.16 %	$ 2.07 B	USA
CollPlant Biotechnologies Ltd. CLGN	3.75 M	$ 4.25	3.16 %	$ 51.9 M	Israel
Cellectar Biosciences CLRB	-651 K	$ 1.8	0.72 %	$ 4.69 M	USA
AbbVie ABBV	394 B	$ 264.34	0.09 %	$ 468 B	USA
Humanigen HGEN	60.3 M	-	-81.12 %	$ 4.28 M	USA
Cocrystal Pharma COCP	7.76 M	$ 1.17	1.74 %	$ 13.2 M	USA
AbCellera Biologics ABCL	1.22 B	$ 12.7	0.4 %	$ 3.79 B	Canada
Abeona Therapeutics ABEO	234 M	$ 5.4	2.65 %	$ 286 M	USA
Collegium Pharmaceutical COLL	2.52 B	$ 22.53	0.2 %	$ 713 M	USA
Corcept Therapeutics Incorporated CORT	3.82 B	$ 116.1	4.93 %	$ 12.1 B	USA
Фармсинтез LIFE	59.3 B	-	-	-	Russia
IGM Biosciences IGMS	276 M	-	-	$ 76.9 M	USA
IMV IMV	23.6 M	-	-	$ 13.1 M	Canada
Kinnate Biopharma KNTE	81.2 M	-	-	$ 123 M	USA
Cardiff Oncology CRDF	115 M	$ 1.24	0.74 %	$ 82.9 M	USA
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
Corbus Pharmaceuticals Holdings CRBP	119 M	$ 7.14	0.19 %	$ 95.1 M	USA
Karuna Therapeutics KRTX	11.7 B	-	-	$ 12.2 B	USA
Curis CRIS	18.9 M	$ 0.83	1.1 %	$ 10.9 M	USA
CorMedix CRMD	276 M	$ 7.85	1.03 %	$ 565 K	USA
Crinetics Pharmaceuticals CRNX	4.14 B	$ 84.95	0.13 %	$ 7.99 B	USA
CRISPR Therapeutics AG CRSP	4.38 B	$ 54.23	0.23 %	$ 4.88 B	Schweiz
Champions Oncology CSBR	102 M	$ 4.9	0.1 %	$ 67.8 M	USA
Chimerix CMRX	-6.72 M	-	-	$ 756 M	USA
Corvus Pharmaceuticals CRVS	324 M	$ 11.62	8.21 %	$ 918 M	USA
Cue Biopharma CUE	18 M	$ 31.41	1.45 %	$ 2.98 B	USA
CEL-SCI Corporation CVM	21.1 M	$ 1.67	2.38 %	$ 13.4 M	USA
Arbutus Biopharma Corporation ABUS	847 M	$ 4.85	0.2 %	$ 929 M	Canada
Cytokinetics, Incorporated CYTK	1.97 B	$ 64.66	0.17 %	$ 7.77 M	USA
Daré Bioscience DARE	21.8 M	$ 0.78	4.73 %	$ 8.72 M	USA
Adagene ADAG	176 M	$ 2.93	2.86 %	$ 173 M	China
DiaMedica Therapeutics DMAC	296 M	$ 7.94	1.4 %	$ 373 M	USA